PHAR (Pharming Group) Short Interest


PHAR Pharming Group PHAR
79 GF Score
Price $13.09
GF Value $14.23
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Pharming Group Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

PHAR vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Pharming Group's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharming Group Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharming Group's Short Interest distribution charts can be found below:

* The bar in red indicates where Pharming Group's Short Interest falls into.


PHAR
79GF Score
Pharming Group PHAR
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Pharming Group (PHAR) Overvalued in 2026?

Based on GuruFocus' analysis, Pharming Group stock appears to be undervalued. The current stock price of $13.09 is trading 8% below its estimated GF Value™ of $14.23. GuruFocus considers Pharming Group to be Fairly Valued.

Key valuation signals for PHAR:

  • Short Interest:
  • GF Value™: $14.23 vs. price of $13.09 (8% below fair value)
  • GF Score™: 79/100 with 1 warning sign

No single metric tells the full story. See the PHAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharming Group Business Description

Address Darwinweg 24, Leiden, ZH, NLD, 2333 CR
Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.
79GF Score

Get the complete analysis for PHAR

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.09
Price
$14.23
GF Value